European Archives - Page 541 of 1125 - European Medical Journal

Pollutants in Food Causing Heightened Allergic Responses

Recent reports have also found dangerously high levels of toxic heavy metals, including cadmium, in several brands of baby food…

Allergic Reactions to mRNA-Based COVID-19 Vaccines Rare and Clinically Manageable

The research further suggests that the minimal allergic reactions could be avoided by manufacturers through the reformulation of vaccines…

Medicine in the Military

Professor Kenneth Stahl looks at the similarities between doctors and pilots, explore working in trauma management within the Kurdish army.

The hard sell of cell and gene therapies

While the potential of cell and gene therapies (CGTs) is huge, the high cost raises concerns from payers. We explore how the industry can drive the adoption of CGTs to ensure that they reach patients around the world, rather than just those in private markets

Seeking solutions to low income low access

During the pandemic, low-to-middle-income countries (LMICs) have often been reliant on vaccine handouts from global initiatives and affluent nations. What are the emerging solutions that could improve access to vaccines in LMICs and self-sufficiency?

What is possible with preventative technology?

Tech giants have seized a huge share of the health and preventive technology market, but how could partnerships between the pharmaceutical and tech industries benefit patients and healthcare systems?

Interview: Neel Basudev

To be honest, my initial foray into the field of diabetes was by chance, as I took on the management of diabetes at the practice when I joined as a salaried general practitioner.

EMJ Oncology 9.1 2021 Feature Image

EMJ Oncology 9.1 2021

Welcome to the latest issue of EMJ Oncology! This e-journal brings you the latest news and novel findings from this year’s European Society…

EMJ Oncology 9.1 2021 Feature Image

Review of the European Society for Medical Oncology (ESMO) Congress 2021: An Enhanced Virtual Experience

AN INTERNATIONAL COLLECTIVE of oncology clinicians and researchers came together to share the most recent updates in patient care and…

A Phase II Prospective Trial of Frontline Cabozantinib in Metastatic Collecting Ducts Renal Cell Carcinoma: the BONSAI Trial (Meeturo 2)

Metastatic collecting ducts carcinoma is biologically poorly characterised and under-represented in prospective randomised trials.